Laurus Labs Limited
NSE:LAURUSLABS.NS
470.4 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 50,408.3 | 60,405.5 | 48,885.4 | 47,232.2 | 27,586.11 | 22,401.14 | 19,971.06 | 18,653.81 | 17,555.06 | 13,143.04 | 11,562.06 | 7,185.11 |
| Cost of Revenue
| 34,569.3 | 27,743.2 | 22,483.2 | 21,973.7 | 14,440.32 | 12,619.44 | 10,872.22 | 10,213.57 | 11,650.75 | 9,516.01 | 8,035.57 | 4,660.23 |
| Gross Profit
| 15,839 | 32,662.3 | 26,402.2 | 25,258.5 | 13,145.79 | 9,781.7 | 9,098.84 | 8,440.24 | 5,904.31 | 3,627.03 | 3,526.49 | 2,524.88 |
| Gross Profit Ratio
| 0.314 | 0.541 | 0.54 | 0.535 | 0.477 | 0.437 | 0.456 | 0.452 | 0.336 | 0.276 | 0.305 | 0.351 |
| Reseach & Development Expenses
| 2,410 | 255.9 | 294.7 | 172.9 | 151.77 | 131.51 | 134.49 | 119.16 | 1,486.28 | 497.95 | 389.89 | 332.54 |
| General & Administrative Expenses
| 666.3 | 638.2 | 618 | 489.4 | 442.52 | 265.2 | 198.55 | 165.64 | 139.31 | 122.14 | 141.29 | 1,062.74 |
| Selling & Marketing Expenses
| 1,344.9 | 1,161.4 | 1,019.8 | 916.5 | 615.32 | 319.6 | 240.88 | 226.48 | 164.86 | 124.61 | 125.44 | 14.77 |
| SG&A
| 11,909.8 | 1,799.6 | 1,637.8 | 1,405.9 | 1,057.84 | 584.8 | 439.43 | 392.12 | 304.17 | 246.75 | 266.73 | 1,077.51 |
| Other Expenses
| 263.4 | 60 | 8.7 | 41 | 46.42 | 57.94 | 42.11 | 28.88 | 0.61 | 2.45 | 3.42 | 0 |
| Operating Expenses
| 11,909.8 | 19,981.2 | 14,675.9 | 11,790.9 | 9,353.25 | 7,651.36 | 6,177.56 | 5,379.78 | 3,079.51 | 2,219.65 | 1,762 | 1,356.35 |
| Operating Income
| 3,929.2 | 12,946.8 | 11,750.6 | 13,506.5 | 3,831.5 | 2,149.36 | 2,924.43 | 3,060.46 | 2,824.8 | 1,407.38 | 1,764.49 | 1,221.09 |
| Operating Income Ratio
| 0.078 | 0.214 | 0.24 | 0.286 | 0.139 | 0.096 | 0.146 | 0.164 | 0.161 | 0.107 | 0.153 | 0.17 |
| Total Other Income Expenses Net
| -1,565.6 | -1,889.5 | -914.1 | -495.4 | -895.4 | -951.84 | -550.27 | -708.51 | -1,149.18 | -741.69 | -555.94 | -360.1 |
| Income Before Tax
| 2,363.6 | 11,089.4 | 10,838.5 | 13,011.1 | 2,936.11 | 1,197.52 | 2,374.16 | 2,351.95 | 1,675.62 | 665.69 | 1,208.55 | 860.99 |
| Income Before Tax Ratio
| 0.047 | 0.184 | 0.222 | 0.275 | 0.106 | 0.053 | 0.119 | 0.126 | 0.095 | 0.051 | 0.105 | 0.12 |
| Income Tax Expense
| 681.5 | 3,123 | 2,514.2 | 3,172.9 | 383.38 | 259.88 | 698.06 | 438.64 | 345.09 | -15.51 | 236.38 | 21.2 |
| Net Income
| 1,605.5 | 7,901.1 | 8,275.2 | 9,835.8 | 2,552.7 | 937.64 | 1,676.1 | 1,902.76 | 1,326.51 | 683.69 | 972.17 | 882.18 |
| Net Income Ratio
| 0.032 | 0.131 | 0.169 | 0.208 | 0.093 | 0.042 | 0.084 | 0.102 | 0.076 | 0.052 | 0.084 | 0.123 |
| EPS
| 2.98 | 14.69 | 15.42 | 18.36 | 4.79 | 1.77 | 3.17 | 4.16 | 3.32 | 2.21 | 3.18 | 2.17 |
| EPS Diluted
| 2.97 | 14.64 | 15.35 | 18.28 | 4.79 | 1.76 | 3.15 | 4.16 | 2.7 | 1.54 | 2.4 | 2.17 |
| EBITDA
| 7,775 | 15,981.9 | 14,105.4 | 15,629.1 | 5,550.14 | 3,589.68 | 4,317.1 | 4,306.3 | 3,693.15 | 2,076.64 | 2,058.08 | 1,445.36 |
| EBITDA Ratio
| 0.154 | 0.265 | 0.289 | 0.331 | 0.201 | 0.16 | 0.216 | 0.231 | 0.21 | 0.158 | 0.178 | 0.201 |